Abnormal response of melanin-concentrating hormone deficient mice to fasting: hyperactivity and rapid eye movement sleep suppression - PubMed (original) (raw)
Abnormal response of melanin-concentrating hormone deficient mice to fasting: hyperactivity and rapid eye movement sleep suppression
J T Willie et al. Neuroscience. 2008.
Abstract
Melanin-concentrating hormone (MCH) is a hypothalamic neuropeptide that has been implicated in energy homeostasis. Pharmacological studies with MCH and its receptor antagonists have suggested additional behavioral roles for the neuropeptide in the control of mood and vigilance states. These suggestions have been supported by a report of modified sleep in the MCH-1 receptor knockout mouse. Here we found that MCH knockout (MCH(-)(/)(-)) mice slept less during both the light and dark phases under baseline conditions. In response to fasting, MCH(-)(/)(-) mice exhibited marked hyperactivity, accelerated weight loss and an exaggerated decrease in rapid eye movement (REM) sleep. Following a 6-h period of sleep deprivation, however, the sleep rebound in MCH(-)(/)(-) mice was normal. Thus MCH(-)(/)(-) mice adapt poorly to fasting, and their loss of bodyweight under this condition is associated with behavioral hyperactivity and abnormal expression of REM sleep. These results support a role for MCH in vigilance state regulation in response to changes in energy homeostasis and may relate to a recent report of initial clinical trials with a novel MCH-1 receptor antagonist. When combined with caloric restriction, the treatment of healthy, obese subjects with this compound resulted in some subjects experiencing vivid dreams and sleep disturbances.
Figures
Figure 1. MCH deficiency promotes wakefulness
(A) Mean wakefulness times for each genotype displayed on an hourly basis (min/h ± SEM) during 24 h of ad libitum feeding. (B) The total times awake over 24 h (min/24 h) under these conditions. _MCH_−/− mice spent more time awake during the dark phase and over 24 h. A significant difference between wild-type and _MCH_−/− mice is indicated by an asterisk.
Figure 2. MCH deficiency induces marked hyperactivity when food is unavailable
(A) Mean hourly distance traveled in the open field (103 cm/h ± SEM) displayed for each genotype during 24 h of ad libitum feeding, followed by 24 h of fasting. Note the pattern of the increase in activity of the _MCH_−/− mice during fasting: hyperactivity occurs during an initial phase at the onset of fasting and this is followed by a second phase towards the end of the subsequent light phase. (B) The mean total distance traveled in the open field (103 cm/24 h ± SEM) during ad libitum feeding and fasting, integrated over 24 h for each genotype. A significant difference between wild-type and _MCH_−/− mice is indicated by an asterisk. For clarity of display, significant differences on the hourly plot during the 24 h of fasting are not shown (all hourly values are significantly different except hours 20:00, 10:00, 11:00, 12:00).
Figure 3. MCH deficiency decreases REM sleep during fasting
Time spent in NREM sleep (A) and REM sleep (B), on an hourly basis (min/h ± SEM) and the total times in these states over 24 h (min/24 h), displayed for each genotype during 24 h of ad libitum feeding, followed by 24 h fasting. Although _MCH_−/− mice respond similarly to wild-type mice during fasting with a reduction NREM sleep, the effect on REM sleep is disproportionately greater in _MCH_−/− mice. See text and table for details. A significant difference between wild-type and _MCH_−/− mice is indicated by an asterisk.
Figure 4. Increase of REM sleep latency in fasting _MCH_−/− mice
The reduction in REM sleep time in _MCH_−/− mice during fasting reflects both an excessive reduction in the number of episodes of REM sleep combined with a failure to increase the mean episode duration. (A) Histograms of the distributions of REM sleep latencies for both genotypes, comparing both ad libitum feeding and fasting conditions. These distributions are different only during fasting, reflecting the shift to long latencies (≥20 min) in _MCH_−/− mice. Under ad libitum feeding, although the overall distributions are not different, a deficit in the occurrence of shorter REM sleep latencies (i.e., ≤ 3 min) is apparent in the _MCH_−/− mice. (B) The mean REM sleep episode duration (min + SEM) displaying the increase in this parameter in wild-type mice during fasting in contrast with the lack of change in the _MCH_−/− mice. A significant difference between wild-type and _MCH_−/− mice is indicated by an asterisk.
Figure 5. Accelerated loss of bodyweight in fasting _MCH_−/− mice
(A) During a 24 h period in the open field with ad libitum access to chow, _MCH_−/− and wild-type mice consumed similar amounts of food (g/24 h/g bodyweight + SEM) (B) During a subsequent 24 h period in the open field without access to food, _MCH_−/− mice lost more weight (cf. Figure 2) (C) _MCH_−/− mice exhibited reduced adiposity as determined NMR body mass analysis under baseline conditions. A significant difference between wild-type and _MCH_−/− mice is indicated by an asterisk.
Figure 6. The sleep homeostat in _MCH_−/− mice is normal
Mice were deprived of sleep by gentle handling for the second 6 h of the light phase, marked by the horizontal bar. (A) The mean hourly times spent awake (min/h ± SEM) in the two genotypes during the subsequent 36 h of recovery sleep time, beginning at the onset of the dark phase (cf. Figure 1). (B) The 12-h NREM and REM sleep times (min/12 h + SEM), during the recovery phase are not different.
Similar articles
- Meta-analysis of melanin-concentrating hormone signaling-deficient mice on behavioral and metabolic phenotypes.
Takase K, Kikuchi K, Tsuneoka Y, Oda S, Kuroda M, Funato H. Takase K, et al. PLoS One. 2014 Jun 12;9(6):e99961. doi: 10.1371/journal.pone.0099961. eCollection 2014. PLoS One. 2014. PMID: 24924345 Free PMC article. - Melanin-concentrating hormone neurons contribute to dysregulation of rapid eye movement sleep in narcolepsy.
Naganuma F, Bandaru SS, Absi G, Mahoney CE, Scammell TE, Vetrivelan R. Naganuma F, et al. Neurobiol Dis. 2018 Dec;120:12-20. doi: 10.1016/j.nbd.2018.08.012. Epub 2018 Aug 24. Neurobiol Dis. 2018. PMID: 30149182 Free PMC article. - Melanin-concentrating hormone is a critical mediator of the leptin-deficient phenotype.
Segal-Lieberman G, Bradley RL, Kokkotou E, Carlson M, Trombly DJ, Wang X, Bates S, Myers MG Jr, Flier JS, Maratos-Flier E. Segal-Lieberman G, et al. Proc Natl Acad Sci U S A. 2003 Aug 19;100(17):10085-90. doi: 10.1073/pnas.1633636100. Epub 2003 Aug 1. Proc Natl Acad Sci U S A. 2003. PMID: 12897241 Free PMC article. - Melanin-concentrating hormone control of sleep-wake behavior.
Monti JM, Torterolo P, Lagos P. Monti JM, et al. Sleep Med Rev. 2013 Aug;17(4):293-8. doi: 10.1016/j.smrv.2012.10.002. Epub 2013 Mar 9. Sleep Med Rev. 2013. PMID: 23477948 Review. - Sleep-Wake Control by Melanin-Concentrating Hormone (MCH) Neurons: a Review of Recent Findings.
Bandaru SS, Khanday MA, Ibrahim N, Naganuma F, Vetrivelan R. Bandaru SS, et al. Curr Neurol Neurosci Rep. 2020 Oct 2;20(12):55. doi: 10.1007/s11910-020-01075-x. Curr Neurol Neurosci Rep. 2020. PMID: 33006677 Review.
Cited by
- Mechanisms of ligand recognition and activation of melanin-concentrating hormone receptors.
He Q, Yuan Q, Shan H, Wu C, Gu Y, Wu K, Hu W, Zhang Y, He X, Xu HE, Zhao LH. He Q, et al. Cell Discov. 2024 May 7;10(1):48. doi: 10.1038/s41421-024-00679-8. Cell Discov. 2024. PMID: 38710677 Free PMC article. - Hypothalamic MCH Neurons: From Feeding to Cognitive Control.
Concetti C, Peleg-Raibstein D, Burdakov D. Concetti C, et al. Function (Oxf). 2023 Oct 27;5(1):zqad059. doi: 10.1093/function/zqad059. eCollection 2024. Function (Oxf). 2023. PMID: 38020069 Free PMC article. Review. - Orexin and MCH neurons: regulators of sleep and metabolism.
Bouâouda H, Jha PK. Bouâouda H, et al. Front Neurosci. 2023 Aug 22;17:1230428. doi: 10.3389/fnins.2023.1230428. eCollection 2023. Front Neurosci. 2023. PMID: 37674517 Free PMC article. Review. - Control of energy homeostasis by the lateral hypothalamic area.
Rossi MA. Rossi MA. Trends Neurosci. 2023 Sep;46(9):738-749. doi: 10.1016/j.tins.2023.05.010. Epub 2023 Jun 22. Trends Neurosci. 2023. PMID: 37353461 Free PMC article. Review. - Sleep, Sirtuin 1 and Alzheimer's disease: A review.
Mehramiz M, Porter T, Laws SM, Rainey-Smith SR. Mehramiz M, et al. Aging Brain. 2022 Sep 9;2:100050. doi: 10.1016/j.nbas.2022.100050. eCollection 2022. Aging Brain. 2022. PMID: 36908890 Free PMC article. Review.
References
- Adamantidis A, Salvert D, Goutagny R, Lakaye B, Gervasoni D, Grisar T, Luppi PH, Fort P. Sleep architecture of the melanin-concentrating hormone receptor 1-knockout mice. Eur J Neurosci. 2008;27:1793–1800. - PubMed
- Ahima RS, Prabakaran D, Mantzoros C, Qu D, Lowell B, Maratos-Flier E, Flier JS. Role of leptin in the neuroendocrine response to fasting. Nature. 1996;382:250–252. - PubMed
- Ahnaou A, Drinkenburg WH, Bouwknecht JA, Alcazar J, Steckler T, Dautzenberg FM. Blocking melanin-concentrating hormone MCH1 receptor affects rat sleep-wake architecture. Eur J Pharmacol. 2008;579:177–188. - PubMed
- Bayer L, Eggermann E, Serafin M, Grivel J, Machard D, Muhlethaler M, Jones BE. Opposite effects of noradrenaline and acetylcholine upon hypocretin/orexin versus melanin concentrating hormone neurons in rat hypothalamic slices. Neuroscience. 2005;130:807–811. - PubMed
- Bittencourt JC, Presse F, Arias C, Peto C, Vaughan J, Nahon JL, Vale W, Sawchenko PE. The melanin-concentrating hormone system of the rat brain: an immuno- and hybridization histochemical characterization. J Comp Neurol. 1992;319:218–245. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- R01 DK069983-02/DK/NIDDK NIH HHS/United States
- P01 DK056116-070002/DK/NIDDK NIH HHS/United States
- P50 MH066172-010003/MH/NIMH NIH HHS/United States
- P01 DK056116-089002/DK/NIDDK NIH HHS/United States
- P01 DK056116-079002/DK/NIDDK NIH HHS/United States
- P01 DK056116-090002/DK/NIDDK NIH HHS/United States
- R01 DK069983-01A1/DK/NIDDK NIH HHS/United States
- P01 DK056116/DK/NIDDK NIH HHS/United States
- P01 DK056116-050002/DK/NIDDK NIH HHS/United States
- P01 DK056116-099002/DK/NIDDK NIH HHS/United States
- P01 DK056116-040002/DK/NIDDK NIH HHS/United States
- HHMI/Howard Hughes Medical Institute/United States
- R01 DK056113-05/DK/NIDDK NIH HHS/United States
- R01 DK069983/DK/NIDDK NIH HHS/United States
- P01 DK056116-030002/DK/NIDDK NIH HHS/United States
- P01 DK056116-06A19002/DK/NIDDK NIH HHS/United States
- P01 DK056116-010002/DK/NIDDK NIH HHS/United States
- R01 DK069983-03/DK/NIDDK NIH HHS/United States
- P01 DK056116-06A10002/DK/NIDDK NIH HHS/United States
- P01 DK056116-020002/DK/NIDDK NIH HHS/United States
- P01 DK056116-080002/DK/NIDDK NIH HHS/United States
LinkOut - more resources
Full Text Sources
Molecular Biology Databases